Jonathan Weinberg - 22 Aug 2024 Form 4 Insider Report for Evolent Health, Inc. (EVH)

Signature
/s/ Jonathan Weinberg
Issuer symbol
EVH
Transactions as of
22 Aug 2024
Net transactions value
-$675,348
Form type
4
Filing time
26 Aug 2024, 20:14:57 UTC
Previous filing
05 Mar 2024
Next filing
04 Mar 2025

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction EVH Class A Common Stock Options Exercise $352,279 +25,253 +15% $13.95 192,280 22 Aug 2024 Direct F1, F2
transaction EVH Class A Common Stock Sale $808,096 -25,253 -13% $32.00 167,027 22 Aug 2024 Direct F1, F2
transaction EVH Class A Common Stock Options Exercise $287,079 +16,887 +10% $17.00 183,914 22 Aug 2024 Direct F1, F2
transaction EVH Class A Common Stock Sale $506,610 -16,887 -9.2% $30.00 167,027 22 Aug 2024 Direct F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction EVH Class A Common Stock Option (right to buy) Options Exercise $0 -25,253 -100% $0.000000 0 22 Aug 2024 Class A Common Stock 25,253 $13.95 Direct F1, F3
transaction EVH Class A Common Stock Option (right to buy) Options Exercise $0 -16,887 -100% $0.000000 0 22 Aug 2024 Class A Common Stock 16,887 $17.00 Direct F1, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 28, 2024.
F2 Includes restricted stock units granted under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission.
F3 The Class A Common Stock Options exercised vested on February 1, 2019, February 1, 2020, February 1, 2021, and February 1, 2022.
F4 The Class A Common Stock Options exercised vested on June 4, 2016, June 4, 2017, June 4, 2018, and June 4, 2019.